
OVERVIEW
Exogenous gene expression in target cells typically necessitates the introduction of viral or non-viral vectors containing exogenous DNA fragments. However, traditional methods involving the direct introduction of exogenous DNA into the human body pose safety concerns in clinical applications. In contrast, in vitro transcribed (IVT) mRNA offers inherent safety advantages due to its non-infectious nature, lack of genomic integration, and natural degradation in cells. Consequently, IVT mRNA is increasingly favored as a tool for gene therapy and novel vaccine research.
Gene Universal boasts a professional and experienced technical team dedicated to custom IVT mRNA synthesis, offering a comprehensive one-stop service from gene synthesis, plasmid preparation, linearized plasmid to IVT mRNA synthesis. Our IVT mRNA ranges in length from 100nt to 5000nt and can be tailored and optimized for various downstream applications. These include template optimization, coding region codon optimization, nucleoside modification, and post-transcriptional modification. IVT mRNA finds applications in diverse research fields such as cell transfection, embryo injection, biopharmaceuticals, and vaccine development.

SERVICE FEATURES
- Free codon optimization enhances mRNA translation efficiency.
- Optimized vector for increased IVT efficiency.
- Customized cap and tail options: 5’ cap (Uncapped, Cap0, Cap1) and 3’ PolyA Tail (No Tail, 120A Tail, customized) to boost mRNA stability and translation efficiency.
- Enhance mRNA translation efficiency and immune evasion performance with modifications like 5-Methyl-CTP and Pseudo-UTP.
- Tailored quality control plan with customized QC projects to meet specific needs.
- One-stop service from DNA template synthesis to IVT mRNA Production.
- Industry-leading turnaround for rapid delivery.
SERVICE OPTIONS
Services Step | Service Content | Turnaround Time | Price |
---|---|---|---|
1. Gene synthesis, Plasmid Preparation | Gene synthesis, Plasmid construction | 2-3 weeks | Inquiry |
Plasmid preparation | |||
2. IVT mRNA Synthesis | Linearized plasmid | 3-4weeks | |
IVT, add 5'cap and 3'PolyA tail, modification | |||
3. Quality Control | The default QC+extra QC item(Customized) | Inquiry |
QC ITEM
QC | Item | Test Method | Specification |
---|---|---|---|
Default | mRNA Length | Agarose gel electrophoresis | Expected size band detected |
mRNA Sequence | Sanger sequencing | Correct DNA template | |
Concentration | Nano drop or Qubit | 1μg/μl(Default) | |
Appearance | Visual inspect | Clear, no visible particles | |
A260/280 | Nano drop | 2.0-2.2 | |
Purity | HPLC | ≥90% | |
Extra(optional)* | Residual DNA template | qPCR | ≤ 10pg/ug |
Endotoxin level | Gel-TAL | ≤0.005 EU/μg | |
Residual Protein | ELISA or Qubit | ≤ 1% | |
Bioburden | Plate | 48h sterile spots |
* Need Charge extra fee for extra QC items.
STANDARD DELIVERABLES
-
DNA Sequence verified via Sanger sequencing
-
Purity tested by gel -electrophoresis
-
Lyophilized mRNA
-
QC report
CASE PRESENTATION
Agarose gel electrophoresis of mRNA
-
Figure 1. Different length of mRNA
-
Figure 2. 200 nt mRNA
mRNA Purity Test
Using linearized plasmid or PCR products as templates ensures mRNA purity exceeds 90%.
-
Figure 3. Linearized plasmid template:Purity Test of 100 nt mRNA
-
Figure 4. PCR product template:Purity Test of 100 nt mRNA
-
If you have custom requests or require any pre-project consultation, please contact us at sales@geneuniversal.com
Online Request Submission
Have a question about sales or support? Our team is ready to help!